beta-Endorphin as One of Important Integral Parts of Tactivin

Nataliya L. Elizarova1, Vitaly Ya. Arion, Vladimir A. Kozlov

  • 1Research Institute for Physico-Chemical Medicine, Moscow, Russia.

Russian Journal of Immunology : RJI : Official Journal of Russian Society of Immunology
|April 11, 2003
PubMed

The discovery of opioid ligand, beta-endorphin (betaEPh), in tactivin widens our knowledge about peptides synthesized by the thymus and allows to study new aspects of integration of the principal elements of immune and nervous systems within the integral immunoneuroendocrine network. Various produced lots of tactivin contain from 2 to 5 pM/l of betaEPh which provides a number of properties of this preparation. betaEPh is an important integral part of tactivin, as the action of tactivin "purified" of betaEPh truly differs from the effects of the total preparation: both in the norm (57 healthy children) and in pathology (30 patients with pyelonephritis), these preparations acted in vitro in different ways on lymphocytes with phenotypes CD3(+), CD4(+), CD8(+), CD38(+), CD22(+). Their influence on the functional activity of monocytes of the peripheral blood differed as well. All these effects of total tactivin and betaEPh-free tactivin were partially realized through &mgr;- and delta-opioid receptors. So, the removal of betaEPh did not "liberate" tactivin from displaying opioid activity, and consequently tactivin contains not only betaEPh, but also other ligands of &mgr;- and delta-types. Tactivin produces a direct and pronounced effect on monocytes of peripheral blood of healthy people and patients. The sensitivity of immunocompetent cells to betaEPh has been shown to be at the various levels and paradoxicality of action of this ligand may be related to the heterogeneity of receptors, through which betaEPh reveals its influence. A wide range of biological activity of tactivin and betaEPh with respect to standard parameters of healthy children is fair and its expediency is obvious as the immunocompetent cells of a healthy child can't help reacting to the peptides incoming from the thymus into blood in cases of antigenic or non-specific responses. One can evaluate the "contribution" of betaEPh to the size and importance of generalized effect of tactivin, as well as the role of intersystemic mediator betaEPh probably may include the initiation and coordination of immunotropic and bioregulating properties of thymic preparation.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...